We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cryo-Save | LSE:CRYO | London | Ordinary Share | NL0009272137 | ORD EUR0.10 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 420.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCRYO RNS Number : 5781L Cryo-Save Group NV 10 May 2010 10 May 2010 Cryo-Save Group N.V. Storage volumes up 5% with strong growth in combined cord storage Cryo-Save Group N.V. (AIM/Euronext: CRYO, or 'the Group'), Europe's leading stem cell bank, announces its trading update for the three months to 31 March 2010. Highlights for the period were: · The number of new customers who stored stem cells from the umbilical cord blood and cord tissue in Q1 2010 was 6,600, up 5% (Q1 2009: 6,300). The total number of samples stored was approximately 128,800 at 31 March 2010 · Over 30% of these new customers opted for the new combined service of storing stem cells from the umbilical cord blood (haematopoietic stem cells) as well as the cord tissue (containing mesenchymal stem cells) · Cryo-Save increased its shareholding of Sejtbank, Hungary and Cryo-Save Czech Republic from 70% to 100%, for a total consideration of EUR1.4 million · Cryo-Save began participation in project Hyperlab, a stem cell research project which is subsidized by the European Commission, in cooperation with several well known research institutes (www.hyperlab.eu/partners.php) · Cryo-Lip :In the first quarter of 2010 Cryo-Save signed contracts with some of the top plastic surgery clinics in Europe for the introduction of the new Cryo-Lip service. Cryo-Lip enables adults, who have already chosen to have liposuction, to store the stem cells collected from the fat. Cryo-Lip will be introduced in a number of countries in the second quarter of 2010 Highlights after 31 March 2010 were: · Cryo-Save acted quickly to minimize the transport disruption caused by the volcanic ash cloud by temporarily using road transport throughout Europe. Almost all samples were received in time, in compliance with Cryo-Save's standards, at its facilities for processing and storage. To handle all samples with the greatest care, the facilities were open 24 hours 7 days a week · As previously announced Arnoud van Tulder took over as Chief Executive on 1 May 2010. Prior to this he was Group CFO. He succeeded co-founder Marc Waeterschoot who will remain an Executive Director and member of the Board. As of 1 June, Mr Perry Buuron is appointed as finance director (non-statutory) Enquiries: +-------------------------------------+---------------------+ | Cryo-Save Group | + 31 (0)575 548998 | +-------------------------------------+---------------------+ | Arnoud van Tulder, Chief Executive | | | Officer | | +-------------------------------------+---------------------+ | Marc Waeterschoot, Executive | | | Director | | +-------------------------------------+---------------------+ | Daniel Stewart & Company plc | + 44 (0)20 7776 | | | 6550 | +-------------------------------------+---------------------+ | Simon Leathers/Emma Earl | | +-------------------------------------+---------------------+ | | | +-------------------------------------+---------------------+ | College Hill (UK) | + 44 (0)20 7457 | | | 2020 | +-------------------------------------+---------------------+ | Adrian Duffield/Rozi Morris | | +-------------------------------------+---------------------+ | | | +-------------------------------------+---------------------+ | SPJ Financiële Communicatie | +31 (0)20 647 8181 | | Amstelveen (NL) | | +-------------------------------------+---------------------+ | Kees Jongsma/Léon Melens | | +-------------------------------------+---------------------+ About Cryo-Save With more than 130,000 samples saved, Cryo-Save is the leading stem cell bank in Europe and one of the fastest growing in the world. Driven by its international business strategy, Cryo-Save is now represented in 38 countries on three continents and has state-of-the-art processing facilities in Belgium, Germany, Dubai, India and France (under construction). This information is provided by RNS The company news service from the London Stock Exchange END MSCEDLFBBEFEBBD
1 Year Cryo-Save Chart |
1 Month Cryo-Save Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions